aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.2850
-0.0091 (-3.09%)
Oct 2, 2026, 1:18 PM EDT - Market open
aTyr Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -60.81 | -74.12 | -64.02 | -50.39 | -45.34 | -33.77 |
Depreciation & Amortization | 1.58 | 1.55 | 1.54 | 2.74 | 1.7 | 1.3 |
Loss (Gain) From Sale of Assets | -0.01 | -0.01 | -0 | -0.01 | -0.09 | 0.01 |
Loss (Gain) From Sale of Investments | -1.27 | -1.85 | -2.71 | -3.17 | 0.53 | 0.37 |
Stock-Based Compensation | 4.97 | 5 | 2.99 | 2.6 | 2.15 | 1.61 |
Other Operating Activities | -0.05 | -0.01 | 0 | -0.01 | -0.01 | -0.01 |
Change in Accounts Receivable | 0.08 | 0.86 | 0.4 | 9.05 | -11.92 | 1.6 |
Change in Accounts Payable | -4.25 | -0.03 | -1.34 | 3.26 | 6.74 | 0.05 |
Change in Other Net Operating Assets | 5.23 | 6.62 | -5.98 | 2.7 | 4.35 | -4.24 |
Operating Cash Flow | -54.54 | -61.99 | -69.12 | -33.22 | -41.89 | -33.08 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0.28 | -0.08 | -0.07 | -4.22 | -1.64 | -0.19 |
Sale of Property, Plant & Equipment | 0.01 | 0.01 | 0.01 | 0.02 | 0.18 | 0.05 |
Investment in Securities | 23.15 | -4.99 | 17.29 | -15.93 | 48.71 | -91.42 |
Investing Cash Flow | 22.88 | -5.05 | 17.23 | -20.13 | 47.25 | -91.57 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -0.54 | -0.5 | -0.39 | -0.07 | - |
Net Debt Issued (Repaid) | -0.56 | -0.54 | -0.5 | -0.39 | -0.07 | - |
Issuance of Common Stock | 29.78 | 66.55 | 40.36 | 66.62 | 5.52 | 110.03 |
Financing Cash Flow | 29.22 | 66.01 | 39.86 | 66.23 | 5.45 | 110.03 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -2.44 | -1.03 | -12.02 | 12.88 | 10.81 | -14.62 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -54.82 | -62.06 | -69.18 | -37.44 | -43.53 | -33.27 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -28852.10% | -32664.74% | -29440.00% | -10605.10% | -419.09% | - |
Free Cash Flow Per Share | -0.56 | -0.67 | -0.93 | -0.70 | -1.53 | -1.74 |
Levered Free Cash Flow | -31.71 | -33.8 | -44.36 | -21.18 | -27.93 | -20.32 |
Unlevered Free Cash Flow | -31.71 | -33.8 | -44.36 | -21.18 | -27.93 | -20.32 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.07 | 0.09 | 0.14 | 0.17 | 0.05 | - |
Change in Working Capital | 1.06 | 7.45 | -6.92 | 15.01 | -0.83 | -2.59 |